PlainRecalls
FDA Drug Moderate Class II Ongoing

Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01

Reported: February 28, 2024 Initiated: February 6, 2024 #D-0341-2024

Product Description

Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01

Reason for Recall

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Details

Units Affected
421 vials involved in this recall (2,448 vials distributed)
Distribution
USA nationwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01. Recalled by Mallinckrodt Hospital Products Inc.. Units affected: 421 vials involved in this recall (2,448 vials distributed).
Why was this product recalled?
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 28, 2024. Severity: Moderate. Recall number: D-0341-2024.